Vicarious Surgical Inc. Files 8-K

TL;DR

Vicarious Surgical filed an 8-K detailing stock and warrant info, formerly D8 Holdings.

AI Summary

Vicarious Surgical Inc. filed an 8-K on June 10, 2024, reporting other events and financial statements. The filing details the company's structure, including its common stock and warrants to purchase shares at an exercise price of $11.50. The company was formerly known as D8 Holdings Corp. before changing its name on May 14, 2020.

Why It Matters

This filing provides an update on Vicarious Surgical Inc.'s corporate structure and financial instruments, including details on their warrants, which could be relevant for investors and potential warrant holders.

Risk Assessment

Risk Level: low — This filing is primarily administrative and corporate information, not indicating immediate financial distress or significant operational changes.

Key Numbers

• 11.50 — Warrant Exercise Price (Price at which warrants can be exercised to purchase shares.)

Key Players & Entities

• Vicarious Surgical Inc. (company) — Registrant
• D8 Holdings Corp. (company) — Former company name
• May 14, 2020 (date) — Date of name change
• June 10, 2024 (date) — Date of report
• 11.50 (dollar_amount) — Warrant exercise price

FAQ

Key Financial Figures

• $0.0001 — tered Class A common stock, par value $0.0001 per share RBOT The New York Stock E
• $11.50 — mon stock, each at an exercise price of $11.50 per share RBOT WS The New York Stoc

Filing Documents

• ea0207560-8k_vicarious.htm (8-K) — 29KB
• ea020756001ex99-1_vicarious.htm (EX-99.1) — 13KB
• 0001213900-24-051236.txt ( ) — 262KB
• rbot-20240610.xsd (EX-101.SCH) — 4KB
• rbot-20240610_def.xml (EX-101.DEF) — 26KB
• rbot-20240610_lab.xml (EX-101.LAB) — 36KB
• rbot-20240610_pre.xml (EX-101.PRE) — 25KB
• ea0207560-8k_vicarious_htm.xml (XML) — 6KB

01 Other Events

Item 8.01 Other Events On June 10, 2024, Vicarious Surgical Inc. (the "Company") issued a press release announcing that the Company's Board of Directors approved effecting a reverse stock split, as approved by the Company's shareholders at the Company's annual shareholder meeting held on June 10, 2024, and fixed a ratio for the reverse stock split at one-for-thirty (1-for-30). A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated June 10, 2024 104 Cover Page Interactive Data File (embedded with the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VICARIOUS SURGICAL INC. By: /s/ Adam Sachs Name: Adam Sachs Title: Chief Executive Officer Date: June 10, 2024 3

View Full Filing

View this 8-K filing on SEC EDGAR